Soligenix
SNGX
#10619
Rank
C$4.83 M
Marketcap
C$0.47
Share price
0.00%
Change (1 day)
-82.34%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -C$17.45 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$12.71 Million a decrease over its 2023 earnings that were of -C$10.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$17.45 Million37.36%
2024 -C$12.71 Million22.96%
2023 -C$10.33 Million-45.74%
2022 -C$19.04 Million11.88%
2021 -C$17.02 Million-32.37%
2020 -C$25.16 Million83.18%
2019 -C$13.74 Million11.57%
2018 -C$12.31 Million19.29%
2017 -C$10.32 Million33%
2016 -C$7.76 Million-19.7%
2015 -C$9.67 Million5.16%
2014 -C$9.19 Million
2010 -C$10.37 Million26.12%
2009 -C$8.23 Million75.1%
2008 -C$4.7 Million-45.38%
2007 -C$8.6 Million-22.84%
2006 -C$11.15 Million66.15%
2005 -C$6.71 Million-16.65%
2004 -C$8.05 Million13.28%
2003 -C$7.11 Million-11.88%
2002 -C$8.06 Million-59.44%
2001 -C$19.88 Million378.18%
2000 -C$4.16 Million-38.53%
1999 -C$6.77 Million-18.43%
1998 -C$8.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.59 B-271,360.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$13.84 B-82,500.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.46 B-62,347.25%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-C$24.68 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$56.75 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.92 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-C$3.75 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA